As of 2025-05-18, the Fair Value of Acura Pharmaceuticals Inc (ACUR) is -0.33 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.02 USD, the upside of Acura Pharmaceuticals Inc is -1,755.99%.
With the market price of 0.02 USD and our fair value calculation, Acura Pharmaceuticals Inc (ACUR) is not a good investment. Investing in ACUR stocks now will result in a potential loss of 1,755.99%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | -5.68 | -3.84 | -3.77 | -1.21 | -0.88 | -3.08 |
| YoY growth | 23.09% | 32.38% | 1.77% | 67.99% | 27.24% | 30.49% |
| Market Cap (mil) | 1.33 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | 30.49% |
| TTM earnings | -0.88 |